Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

Herpes Zoster Disease Clinical Trial

Official title:

Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01519570
• Other study ID #: 2010H0290
• Status: Completed
• Phase: N/A
• Start date: March 2011
• Est. completion date: December 2011

Study information

• Verified date: August 2018
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2589
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Greater than 60 years of age

Exclusion Criteria:

• Documented herpes zoster vaccine in the EMR

Related Conditions & MeSH terms

• Herpes Zoster
• Herpes Zoster Disease

Intervention

Other:
• An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.

Locations

Country	Name	City	State
United States	The Ohio State University Martha Morehouse General Internal Medicine Clinic	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants Who Received the Herpes Zoster Vaccine	Six months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups.	6 months
Secondary	Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email	Difference in vaccination rates between patients sent communications via US postal service (USPS) and those sent communications via electronic patient portal (EPP)	6 months
Secondary	Amount of Time Required by a Clinical Pharmacist to Manage This Workflow		6 months